09 October 2017

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

09 October 2017 | n=30

  1. Karlsson I, Borggren M, Jensen SS, Heyndrickx L, et al.
    Immunization with clinical HIV-1 Env proteins induces broad antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies in a rabbit vaccination model.
    AIDS Res Hum Retroviruses 2017.

  2. Dezzutti CS, Park SY, Marks K, Lawlor S, et al.
    Heterogeneity of HIV-1 replication in ectocervical and vaginal tissue ex vivo.
    AIDS Res Hum Retroviruses 2017.

  3. Roberson JL, Lagasca AM, Kan VL.
    Comparison of the Hepatitis C Continua of Care between HCV/HIV Co-Infected and HCV Mono-Infected Patients in Two Treatment Eras during 2008-2015.
    AIDS Res Hum Retroviruses 2017.

  4. Hileman CO, McComsey GA.
    The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status in Treated HIV-Infection.
    AIDS Res Hum Retroviruses 2017.

  5. Matsuda EM, Coelho LP, Romero G, Moraes MJ, et al.
    High prevalence of drug resistance mutations among patients failing first-line antiretroviral therapy and predictors of virological response 24 weeks after switch to second-line therapy in Sao Paulo State, Brazil.
    AIDS Res Hum Retroviruses 2017.

  6. Zanolini A, Chipungu J, Vinikoor M, Bosomprah S, et al.
    HIV self-testing in Lusaka Province, Zambia: acceptability, comprehension of testing instructions, and individual preferences for self-test kit distribution in a population-based sample of adolescents and adults.
    AIDS Res Hum Retroviruses 2017.

  7. Viegas EO, Tembe N, Nilsson C, Meggi B, et al.
    Intradermal HIV-1 DNA immunization using needle-free Zetajet<sup>TM</sup> injection followed by HIV-modified vaccinia virus Ankara vaccination is safe and immunogenic in Mozambican young adults: a phase I randomized controlled trial.
    AIDS Res Hum Retroviruses 2017.

  8. Casseb J, Fonseca LAM, Duarte A.
    Is it possible to control HIV infection in a middle-income country through a multidisciplinary approach?
    AIDS Res Hum Retroviruses 2017.

  9. Alemnji GA, Chase M, Branch S, Guevara G, et al.
    Improving Laboratory Efficiency in the Caribbean to Attain the World Health Organization HIV Treat All Recommendations.
    AIDS Res Hum Retroviruses 2017.

  10. Andrews B, Semler MW, Muchemwa L, Kelly P, et al.
    Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial.
    JAMA 2017;318:1233-1240.

  11. Godfrey C, Thigpen MC, Crawford KW, Jean-Phillippe P, et al.
    Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation.
    J Infect Dis 2017.

  12. Asmuth DM, Thompson CG, Chun TW, Ma ZM, et al.
    Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal GALT Immune Reconstitution in HIV-infected Patients Initiating Antiretroviral Therapy.
    J Infect Dis 2017.

  13. Liu Y, Gaisa MM, Wang X, Swartz TH, et al.
    Immune Microenvironments of Anal Cancer Precursors Differ by HIV-serostatus, Affecting Ablation Outcomes.
    J Infect Dis 2017.

  14. Noguera-Julian M, Edgil D, Harrigan PR, Sandstrom P, et al.
    Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance.
    J Infect Dis 2017.

  15. Weitzmann MN, Vikulina T, Roser-Page S, Yamaguchi M, et al.
    Homeostatic Expansion of CD4+ T-cells Promotes Cortical and Trabecular Bone Loss while CD8+ T-cells Induce Trabecular Bone Loss Only.
    J Infect Dis 2017.

  16. Godfrey C, Bobkova M, Boucher C, Ravasi G, et al.
    Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.
    J Infect Dis 2017.

  17. Ning T, Wolfe A, Nie J, Huang W, et al.
    Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization.
    J Infect Dis 2017.

  18. Chikata T, Murakoshi H, Koyanagi M, Honda K, et al.
    Control of HIV-1 by an HLA-B*52:01-C*12:02 protective haplotype.
    J Infect Dis 2017.

  19. Boeijen LL, Montanari NR, de Groen RA, van Oord GW, et al.
    Mucosal-associated invariant T (MAIT) cells are more activated in chronic hepatitis B, but not depleted in blood: reversal by antiviral therapy.
    J Infect Dis 2017.

  20. Ake JA, Schuetz A, Pegu P, Wieczorek L, et al.
    Safety and Immunogenicity of PENNVAX(R)-G DNA Prime Administered by Biojector(R) 2000 or CELLECTRA(R) Electroporation Device with Modified Vaccinia Ankara-CMDR Boost.
    J Infect Dis 2017.

  21. McLaren PJ, Pulit SL, Gurdasani D, Bartha I, et al.
    Evaluating the impact of functional genetic variation on HIV-1 control.
    J Infect Dis 2017.

  22. Liu Z, Fang Q, Zuo J, Chen Y, et al.
    Global Epidemiology of Human Herpesvirus 8 in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
    J Med Virol 2017.

  23. Amponsah-Dacosta E, Selabe SG, Mphahlele MJ.
    Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.
    J Med Virol 2017.

  24. Bracq L, Xie M, Lambele M, Vu LT, et al.
    T cell-macrophage fusion triggers multinucleated giant cell formation for HIV-1 spreading.
    J Virol 2017.

  25. Gift SK, Leaman DP, Zhang L, Kim AS, et al.
    Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at its Apex.
    J Virol 2017.

  26. Pokrovsky V.
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet 2017;390:1618-1619.

  27. Kazatchkine MD.
    Health in the Soviet Union and in the post-Soviet space: from utopia to collapse and arduous recovery.
    Lancet 2017;390:1611-1612.

  28. Estes JD, Kityo C, Ssali F, Swainson L, et al.
    Defining total-body AIDS-virus burden with implications for curative strategies.
    Nat Med 2017.

  29. Cohen MS, Corey L.
    Broadly neutralizing antibodies to prevent HIV-1.
    Science 2017;358:46-47.

  30. Nahabedian J, Sharma A, Kaczmarek ME, Wilkerson GK, et al.
    Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry.
    Virology 2017;512:180-186.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

16 July 2018

09 July 2018

02 July 2018

25 June 2018

18 June 2018

09 October 2017

Multidisciplinary Journal Club

  1. Johnson SB, Park HS, Gross CP, Yu JB, et al.
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst. 2018;110.

  2. Adams TD, Davidson LE, Litwin SE, Kim J, et al.
    Weight and Metabolic Outcomes 12 Years after Gastric Bypass.
    N Engl J Med. 2017;377:1143-1155.

  3. Postuma RB, Anang J, Pelletier A, Joseph L, et al.
    Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): A randomized trial.
    Neurology. 2017 Sep 27. pii: 10.1212/WNL.0000000000004568.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016